Fusion Antibodies, a drug discovery spin-out of Queen’s University Belfast, will be able to further develop its capacity to produce cancer-fighting drugs following support from government agency Invest NI (Northern Ireland). The agency, which is distributing cash from the European Regional Development Fund, will put £63,304 ($103k) into the firm, of which £22,704 is earmarked…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
